This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   June 09, 2015


Discovery of how bacteria survive antibiotics may improve treatment of infectious diseases
Cell Press via Infection Control Today
A study published June 4 in Molecular Cell reveals that these so-called persisters form in response to adverse conditions through the action of a molecule called Obg, which plays an important role in all major cellular processes in multiple bacterial species. By revealing a shared genetic mechanism underlying bacterial persistence, the study paves the way for novel diagnostic tools and more effective treatment strategies for a range of bacterial infections.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Study: Immunity enzyme defends against tuberculosis infection
UT Southwestern Medical Center via Infection Control Today
A study by researchers at the University of Texas Southwestern Medical Center has identified how an enzyme involved in protecting the body from pathogens senses Mycobacterium tuberculosis, a bacterial pathogen that infects millions of people worldwide and causes about 1.5 million deaths annually. The new finding has potential implications for the development of immunity-based therapies to treat tuberculosis, which typically takes months to eradicate and has become increasingly resistant to antibiotics.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Preliminary incidence and trends of infection with pathogens transmitted commonly through food
Foodborne illnesses represent a substantial, yet largely preventable, health burden in the United States. In 10 U.S. geographic areas, the Foodborne Diseases Active Surveillance Network monitors the incidence of laboratory-confirmed infections caused by nine pathogens transmitted commonly through food. This report summarizes preliminary data and describes changes in incidence.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Looking to upgrade your education through online coursework?
Want customizable educational options for current employees?
Looking for affordable, online continuing education?

University of North Dakota MLS has answers!


1st-in-man clinical trial for Hunter syndrome underway at Emory
Health Canal
A first-in-man clinical trial, testing a newly developed drug for a rare genetic condition called Hunter syndrome is underway at Emory University. Now, Emory researchers are testing idursulfase to create a new method of delivery that will include the brain. This is the first time this medication combination, called AGT-182, has been tested in a human.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

1st steps taken for regenerating whole limb
Medical News Today
The first steps toward developing "bioartificial" replacement limbs that are suitable for transplantation have reportedly been taken by a team at Massachusetts General Hospital in Boston. The researchers stripped away tissue from the rats' forelimbs, but preserved the primary vasculature and nerve matrix.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Muscle biopsy and clinical and laboratory features neuromuscular disease
Muscle biopsy plays an integral role in evaluation of the patient with neuromuscular disease. With occasional exceptions, it is an essential element in the assessment of a patient with suspected myopathy. In addition, muscle biopsy is also sometimes indicated for the diagnosis of various systemic disorders and the evaluation of suspected neuropathic disease, particularly for the purpose of distinguishing between a neurogenic disorder with an atypical presentation and a primary myopathic disorder.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

GW Online Programs In MLS

Get ASCP certified in MLS through our fully online Bachelor’s degree or Post-Baccalaureate Certificate.

Or, earn your MSHS degree in Molecular Diagnostic Sciences, Clinical and/or Translational Microbiology, MLS, or Immunohematology & Biotechnology. Online and hybrid programs available.

Visit our website or email us at for more information.

Mayo Clinic researchers determine that use of high-definition optical technology enables physicians to identify precancerous polyps immediately
DARK Daily
High-definition optical technology is reaching the point where gastroenterologists are able to identify precancerous polyps with 96 percent accuracy during colonoscopies, according to a recent study conducted at the Mayo Clinic. Pathologists will want to pay close attention to the published findings of this study. That's because gastroenterological biopsies represent a significant proportion of specimens referred to anatomic pathologists.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Easier HDL and LDL Linearity Testing
VALIDATE® LP for Easier Calibration Verification / Linearity Testing of HDL and LDL. VALIDATE® LP uses human-sourced materials for better system response. Test kits contain Apo-AI and Apo-B as part of the HDL and LDL components. Multiple product configurations meet the needs of the many instrument systems available, virtually eliminating dilutions while maximizing reportable ranges. Visit or call 1-800-377-9684 to learn more.

Shingles vaccine appears to cut odds of long-term pain
HealthDay News
Even when shingles vaccination does not prevent the disease, it reduces the risk of long-term pain that can occur as a complication of the condition, according to a new study. Although the U.S. Advisory Council on Immunization Practices recommends shingles vaccination for people 60 and older, vaccination rates remain low, the researchers say.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed an issue of the eNewsBytes? Click here to visit the eNewsBytes archive page.

Web-based competency testing
A powerful web-based program for proficiency testing of blood and body-fluid differentials. Instant access anywhere! Try it out FREE now. MORE
Wear it proudly! AMT certified members are knowledgeable, passionate and committed to providing quality healthcare. AMT members are lifelong learners. MORE

Study: Early HIV treatment halves risk of serious complications
Health Canal
An international study led by the University of New South Wales's Kirby Institute has shown immediate treatment for people diagnosed with HIV can halve their risk of HIV-related serious disease or death. The study was terminated ahead of schedule after interim results provided conclusive evidence that immediate treatment with anti-retroviral therapy is clinically superior compared to deferred treatment.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    Global trial: HIV drugs should be taken right after diagnosis (HealthDay News)
Future vaccine may help lower blood pressure long-term (Health Canal)
Large ovarian cancer study reveals new clues on genetics of chemoresistance (Medical News Today)
New findings shed light on complexities of emerging zoonotic malaria (London School of Hygiene & Tropical Medicine via ScienceDaily)
Researchers oppose unvalidated gene panel tests for cancer links (Reuters)

Don't be left behind. Click here to see what else you missed.

ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Katina Smallwood, Senior Editor, 469.420.2675   
Contribute news

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

June 2, 2015
May 28, 2015
May 26, 2015
May 19, 2015

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063